Clinical Characteristics and Survival Outcomes of Patients with De Novo Metastatic Breast Cancer.

Hanan Almasri Ayah ErjanHebah AbudawabaKhaled AshouriSara MheidAnoud AlnsourHikmat Abdel-Razeq

Published in: Breast cancer (Dove Medical Press) (2022)

The overall survival of patients with dnMBC remains poor. Better understanding of the disease behavior and factors affecting survival is required for optimal utilization of available regimens and new drugs to hopefully improve patients' outcomes.

Keyphrases

metastatic breast cancer
end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
peritoneal dialysis
free survival
type diabetes